Literature DB >> 19717845

Ticagrelor--is there need for a new player in the antiplatelet-therapy field?

Albert Schömig.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19717845     DOI: 10.1056/NEJMe0906549

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

Review 1.  Optimization of Antiplatelet Therapy in STEMI.

Authors:  Abhishek Sinha; Kush Agrawal; Rahul Sakhuja
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

Review 2.  Antithrombotic drugs: pharmacology and implications for dental practice.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2013

Review 3.  Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.

Authors:  Jolanta M Siller-Matula; Julia Krumphuber; Bernd Jilma
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

Review 4.  [Therapy strategies for acute coronary syndrome and after coronary interventions. Antiplatelet agents and anticoagulants].

Authors:  D Divchev; C Nienaber; H Ince
Journal:  Internist (Berl)       Date:  2011-11       Impact factor: 0.743

5.  State-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.

Authors:  Dharam J Kumbhani; Steven P Marso; Carlos A Alvarez; Darren K McGuire
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-01

Review 6.  Ticagrelor: a review of its use in the management of acute coronary syndromes.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

7.  [Periinterventional antiplatelet therapy: from bench to bedside].

Authors:  D Braun; C Schulz; D Sibbing; S Massberg
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

Review 8.  [Atherothrombosis : Novel therapeutic strategies].

Authors:  O Soehnlein
Journal:  Herz       Date:  2018-03       Impact factor: 1.443

Review 9.  Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.

Authors:  Rakesh K Sharma; Hanumanth K Reddy; Vibhuti N Singh; Rohit Sharma; Donald J Voelker; Girish Bhatt
Journal:  Vasc Health Risk Manag       Date:  2009-11-16

Review 10.  Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor.

Authors:  Margaret M Marczewski; Marek Postula; Dariusz Kosior
Journal:  Vasc Health Risk Manag       Date:  2010-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.